Meet the Team: Garfield Bolt

NetDimensions’ Inside Sales Representative, Garfield Bolt, enjoys crossing time zones and locations to put his technical and public speaking skills to excellent use. This new resident of Atlanta plays a key role in making sure organizations have their precise needs satisfied by our solutions.

Let’s get to know Garfield better.

A photo of Garfield Bolt smiling

NextSteps 2018: Inspiration and insights at our annual conference

NextSteps 2018, NetDimensions’ global user conference, proved a typically insightful day as our collaborators met in London. Here are a few of our highlights…

With guests from all over the world representing a diverse variety of sectors, this year’s conference was a vibrant event packed with great discussions and insights.

During the course of the one-day get-together in London, we heard from thought leaders, learning pioneers, technical experts and L&D specialists.

Together with invaluable insights and success stories, there was a real sense of mutual encouragement and collaboration.

A photo of a person talking on stage at NetDimensions NextSteps 2018

How a pharmaceutical market leader used NetDimensions to eliminate compliance risk

Keeping workforces compliant with legislation is a major challenge in the pharmaceutical industry – and failing to do so can be extremely risky. With a seamless integration of NetDimensions technology, one market leader’s L&D team ensured they could face compliance risk and meet the demands of regulators such as FDA and EMA.

The ability to manage compliance risk is expected to become more crucial than ever in the pharmaceutical and life sciences sector by 2020 [1].

Businesses need to protect themselves from the heavy costs of non-compliance. A culture of quality is crucial to reducing and eliminating exposure to risks including financial penalties, rescinded regulatory approvals and reputational damage.

Demystifying the process of complying with 21 CFR Part 11

There’s been a lack of clarity around what’s needed to comply with 21 CFR Part 11, the US Food and Drug Administration’s regulations for inspecting electronic training records held by organizations.

Implementing electronic signatures and being able to clearly audit their use has often been a considerable challenge for businesses in the life sciences and pharma sectors.

This is an essential requirement for companies in these sectors looking to comply with the FDA’S CFR regulations. In-depth and rigorous auditing is increasingly sought-after by organizations in other sectors too, such as healthcare.

A photo of a person sitting at a laptop holding a bottle of manufactured pharma drugs as an illustration of the pharma 21 CFR Part 11 regulation

Future-proof your organization with the right talent development strategy

How can a strong talent development strategy help prepare your organization for the future? Find out in this blog based on LinkedIn’s 2018 Workplace Learning Report.

LinkedIn’s 2018 Workplace Learning Report paints an interesting picture of the challenges organizations face to maximize the potential of their workforce. We take a look at the key insights and what they could mean for your talent development strategy.

The report surveyed 4,000 professionals made up of 1,200 L&D or HR professionals, 400 people managers, 200 executives, and 2,200 learners from North America, Europe, and Asia.

a talent development strategy can boost business success